IRadimed has a total of 27 patents globally, out of which 23 have been granted. Of these 27 patents, more than 77% patents are active. The United States of America is where IRadimed has filed the maximum number of patents, followed by Europe and Germany. Parallelly, United States of America seems to be the main focused R&D center and also is the origin country of IRadimed.
IRadimed was founded in 2004. IRadimed provides non-magnetic intravenous infusion pump systems for use during magnetic resonance imaging procedures. As of September 2022, IRadimed has a market cap of $412.63 Million.
Do read about some of the most popular patents of IRadimed which have been covered by us in this article and also you can find IRadimed patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over IRadimed patent portfolio.
How many patents does the Founder and CEO of IRadimed have?
The Founder and CEO Roger Susi have 40 patents.
How many patents does IRadimed have?
IRadimed has a total of 27 patents globally. These patents belong to 5 unique patent families. Out of 27 patents, 21 patents are active.
How Many Patents did IRadimed File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Iradimed Applications Filed||Iradimed Patents Granted|
How many IRadimed patents are Alive/Dead?
How Many Patents did IRadimed File in Different Countries?
Countries in which IRadimed Filed Patents
|United States Of America||19|
Where are Research Centers of IRadimed Patents Located?
10 Best IRadimed Patents
US7553295B2 is the most popular patent in the IRadimed portfolio. It has received 85 citations so far from companies like Fresenius Medical Care Deutschland Gmbh, Deka Products Limited and Bayer Healthcare Llc.
Below is the list of 10 most cited patents of IRadimed:
|Publication Number||Citation Count|
What Percentage of IRadimed US Patent Applications were Granted?
IRadimed (Excluding its subsidiaries) has filed 13 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 11 have been granted leading to a grant rate of 91.6%.
Below are the key stats of IRadimed patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for IRadimed?
|Law Firm||Total Applications||Success Rate|
|Knobbe Martens Olson & Bear Llp||13||91.67%|
List of IRadimed Patents –
|US11291767B2||System And Method For Communication With An Infusion Device|
|US11268506B2||Fluid Pumps For Use In Mri Environment|
|US11045600B2||Liquid Infusion Apparatus|
|US10821223B2||Liquid Infusion Apparatus|
|US10617821B2||System And Method For Communication With An Infusion Device|
|US9878089B2||Liquid Infusion Apparatus|
|US9861743B2||System And Method For Communication With An Infusion Device|
|US8690829B2||Non-Magnetic Medical Infusion Device|
|US8500694B2||System And Method For Communication With An Infusion Device|
|US8469932B2||Liquid Infusion Apparatus|
|US8262642B2||Iv Fluid Infusion Assembly|
|US8150493B2||Patient Infusion And Imaging System|
|US8105282B2||System And Method For Communication With An Infusion Device|
|US7753882B2||Non-Magnetic Medical Infusion Device|
|US7553295B2||Liquid Infusion Apparatus|
|US7404809B2||Non-Magnetic Medical Infusion Device|
|US7267661B2||Non-Magnetic Medical Infusion Device|
|US20210322671A1||Liquid Infusion Apparatus|
|US20150374537A1||Mri-Safe Patient Thermal Management System|
|EP1802362B1||Non-Magnetic Medical Infusion Device|
|EP1530440B1||Non-Magnetic Medical Infusion Device|
|EP3501389A1||Fluid Pumps For Use In Mri Environment|
|WO2007058951A8||Peristaltic Liquid Infusion Apparatus|
|DE602005037119T2||Non-Magnetic Medical Infusion Device|
|DE60330568D1||Non-Magnetic Medical Infusion Device|
|JP5001845B2||Non-Magnetic Medical Infusion Device|
|JP4597970B2||Liquid Injection Device According Mri Environment|
EXCLUSIVE INSIGHTS COMING SOON!